Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-4 of 4
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
19-Apr-2019Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3Tornatore, L; Capece, D; D'Andrea, D; Begalli, F; Verzella, D, et al
17-Sep-2013Combined Inhibition of p97 and the Proteasome Causes Lethal Disruption of the Secretory Apparatus in Multiple Myeloma CellsAuner, HW; Moody, AM; Ward, TH; Kraus, M; Milan, E, et al
26-May-2017De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trialClark, RE; Polydoros, F; Apperley, JF; Milojkovic, D; Pocock, C, et al
30-Nov-2018The argument for using imatinib in CMLClaudiani, S; Apperley, JF; Imperial College Trust; Novartis Pharmaceuticals UK Limited; Leuka, et al